Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis

Kidney International

Volumn 57, Issue 6, 2000, Pages 2343-2349

  Honkanen, Eero O ^a   Teppo, Anna Maija ^a   Grönhagen Riska, Carola ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Glomerulonephritis; Growth factors; Immune process; Proteinuria; Sandwich enzyme immunoassay; Vascular permeability

Indexed keywords

CREATININE; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; URINARY EXCRETION;

EID: 0034040586     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00094.x     Document Type: Article

References (45)

1. 1. GLASSOCK RJ, COHEN AH, ADLER SF: Primary glomerular diseases, in The Kidney, edited by Brenner BM, Philadelphia, W.B. Saunders, 1996, pp 1392-1497
2. 2. FARQUHAR MG, SAITO A, KERJASCHKI D, LUNDSTOdie;M M, ORLANDO RA: The Heymann nephritis antigenic complex: Megalin (gp330) and RAP. J Am Soc Nephrol 6:35-47, 1995
3. 3. KERJASCHKI D: The pathogenesis of membranous glomerulonephritis: From morphology to molecules. Virchows Arch B Cell Pathol 158:253-271, 1990
4. 4. ROTHER K, HÄNCH GM, RAUTERBERG EW: Complement in inflammation: Induction of nephritides and progress to chronicity. Int Arch Allergy Appl Immunol 4:23-37, 1991
5. 5. NEALE TJ, RÜGER BM, MACAULAY H, DUBAR R, HASAN Q, BOURKE A, MURRAY-MACINTOSH RP, KITCHING AR: Tumor necrosis factor-α is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol 146:1444-1454, 1994
6. 6. COUSER WG: Pathogenesis of glomerular damage in glomerulonephritis. Nephrol Dial Transplant 13(Suppl 1):10-15, 1998
7. 7. HONKANEN E, TÖRNROTH T, GRÖNHAGEN-RISKA C, SANKILA R: Long-term survival in idiopathic membranous glomerulonephritis: Can the course be clinically predicted? Clin Nephrol 41:127-134, 1994
8. 8. CATIRAN DC, PEI Y, GREENWOOD CMT, PONTICELLI C, PASSERINI P, HONKANEN E: Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications. Kidney Int 51:901-907, 1997
9. 9. SCHIEPPATI A, MOSCONI L, PERNA AL, MECCA G, BERTANI T, GARATTINI S, REMUZZI G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329:85-89, 1993
10. 10. PONTICELLI C, ZUCCHELLI P, PASSERINI P, CESANA B, LOCATELLI F, PASQUALI S, SASDELLI M, REDAELLI B, GRASSI C, POZZI C, BIZZARRI D, BANFI G: A 10-year follow-up of a randomized study with methyl-prednisolone and chlorambucil in membranous nephropathy. Kidney Int 48:1600-1604, 1995
11. 11. CATIRAN D, GREENWOOD C, RITCHIE S, BERNSTEIN K, CHURCHILL DN, CLARK WF, MORRIN PA, LAVOIF S, THE CANADIAN GLOMERULONEPHRITIS STUDY GROUP: A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 47:1130-1135, 1995
12. 12. FERRARA N, HENZEL WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858, 1989
13. 13. FERRARA N, HOUCK K, JAKEMAN L, LEUNG DW: Molecular and biological properties of the vascular endothelial growth factor. Endocr Rev 13:18-32, 1992
14. 14. DE VRIES CD, ESCOBEDO JA, UENO H, HOUCK K, FERRARA N, WILLIAMS LT: The fins-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991, 1992
15. 15. TERMAN BI, DOUGHER-VERMAZEN M, CARRION ME, DIMITROV D, ARMELLINO DC, GOSPODAROWICZ D, BOHLEN P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187:1579-1586, 1992
16. 16. BROWN LF, BERSE B, TOGNAZZI K, MANSEAU EJ, VAN DE WAIER L, SENGER DR, DVORAK HF, ROSEN S: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42:1457-1461, 1992
17. 17. GRÖNE H-J, SIMON M, GRÖNE EF: Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 177:259-267, 1995
18. 18. HALHA A, SOLIN M-L, JALANKO H, HOLMBERG, C, MIETTINEN A, HOLTHOFER H: Mechanisms of proteinuria: Vascular permeability factor in congenital nephrotic syndrome of the Finnish type. Pediatr Res 40:652-657, 1996
19. 19. IIJIMA K, YOSHIKAWA N, CONOLLY DT, NAKAMURA H: Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 44:959-966, 1993
20. 20. NOGUCHI K, YOSHIKAWA N, ITO-KARIYA S, INOUE Y, HAYASHI Y, ITO H, NAKAMURA H, IIJIMA K: Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9:1815-1825, 1998
21. 21. SHULMAN K, ROSEN S, TOGNAZZI K, MANSEAU EJ, BROWN LF: Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 7:661-666, 1996
22. 22. ROSEN S, TÖRNROTH T, BERNARD DB: Membranous glomerulonephritis, in Renal Pathology: With Clinical and Functional Correlations, edited by TISHER CC, BRENNER BM, Philadelphia, JB Lippincott, 1994, pp 258-293
23. 23. CHURG J, BERNSTEIN J, GLASSOCK RJ: Renal disease, in Classification and Atlas of Glomerular Diseases (2nd ed), Tokyo, Ikagu-Shoin, 1995
24. 24. TEPPO AM, MAURY CPJ: Radioimmunoassay of tumor necrosis factor in serum. Clin Chem 33:2024-2027, 1987
25. 25. HONKANEN E, TEPPO A-M, TÖRNROTH T, GROOP P-H, GRÖNHAGEN-RISKA C: Urinary transforming growth factor-β1 in membranous glomerulonephritis. Nephrol Dial Transplant 12:2562-2568, 1997
26. 26. TEPPO A-M: Immunoturbidimetry of albumin and immunoglobulin G in urine. Clin Chem 28:1359-1361, 1982
27. 1-microglobulin: Its measurement and clinical significance. J Clin Lab Anal 4:376-384, 1990
28. 28. ZACHARY I: Vascular endothelial growth factor: How it transmits its signal. Exp Nephrol 6:480-487, 1998
29. 29. DETMAR M, BROWN LF, CLAFFEY KP, YEO KT, KOCHER O, JACKMAN RW, BERSE B, DVORAK HF: Overexpression of vascular endothelial cell growth factor and its receptors in psoriasis. J Exp Med 180:1141-1146, 1994
30. 30. BROWN LF, HARRIST TJ, YEO K-T, STAHLE-BACKDAHL M, JACKMAN RW, BERSE B, TOGNAZZI K, DVORAK HF, DETMAR M: Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 104:744-749, 1995
31. 31. KITAMOTO Y, TOKUNAGA H, TOMITA K: Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Invest 15:2351-2357, 1997
32. 32. SIMON M, GRÖNE H-J, JÖHREN O, KULLMER J, PLAIF KH, RISAU W, FUCHS E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and adult kidney. Am J Physiol 268(2 Pt 2):F240-F250, 1995
33. 33. HORITA Y, MIYAZAKI M, KOJI T, KOBAYASHI N, SHIBUYA M, RAZZAQUE MS, CHENG M, OZONO Y, KOHNO S, TAGUCHI T: Expression of vascular endothelial growth factor and its receptors in rats with protein-overload nephrosis. Nephrol Dial Transplant 13:2519-2528, 1998
34. 34. WEBB NJA, WATSON CJ, ROBERIS ISD, BOTTOMLEY MJ, JONES CA, LEWIS MA, POSTLETHWAITE RJ, BRENCHLEY PEC: Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome. Kidney Int 55:1063-1071, 1999
35. 35. KLANKE B, SIMON M, RÖCKL W, WEICH HA, SIOLIE H, GRÖNE H-J: Effects of vascular endothelial cell growth factor (VEGF)/ vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney. Nephrol Dial Transplant 13:875-885, 1998
36. 36. IRUELA-ARISPE L, GORDON K, HUGO C, DUIJVESTIJN AM, CLAFFEY KP, REILLY M, COUSER WG, ALPERS CE, JOHNSON RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 147:1715-1727, 1995
37. 37. NITTA K, UCHIDA K, HONDA K, HORITA S, HAYASHI T, ISHIZUKA T, YUMURA W, NIRFI H: Serum vascular endothelial growth factor concentration in rapidly progressive glomerulonephritis. (letter) Nephron 80:357-358, 1998
38. 38. BROGI E, SCHATTEMAN G, WU T, KIM EA, VARTICOVSKI L, KEYT B, ISNER JM: Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97:469-476, 1996
39. 39. VASIR B, AIELLO LP, YOON K-H, QUICKEL RR, BONNER-WEIR S, WEIR GC: Hypoxia induces vascular endothelial growth factor gene and protein expression in cultures rat islet cells. Diabetes 47:1894-1903, 1998
40. 40. WEINGARTNER K, BEN-SASSON SA, STEWART R, RICHIE JP, RIED-MILLER H, FOLKMAN J: Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: An in vitro model for assessment. J Urol 159:465-470, 1998
41. 41. CREW JP, O'BRIEN T, BICKNELL R, FUGGLE S, CRANSTON D, HARRIS AL: Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol 161:799-804, 1999
42. 42. HONKANEN E, TEPPO A-M, MERI S, LEHTO T, GRÖNHAGEN-RISKA C: Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 9:1553-1559, 1994
43. 43. CANTON AD: Adhesion molecules in renal disease. Kidney Int 48:1687-1696, 1995
44. 44. HONKANEN E, VON WILLEBRAND E, TEPPO A-M, TÖRNROTH T, GRÖNHAGEN-RISKA C: Adhesion molecules and urinary tumor necrosis factor-α in idiopathic membranous glomerulonephritis. Kidney Int 53:909-917, 1998
45. 45. PATTERSON C, PERRELLA MA, ENDEGE WO, YOSHIZUMI M, LEE M-E, HABER E: Downregulation of vascular growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells. J Clin Invest 98:490-496, 1996